Ramsey Health Care FY16 Earnings Result

Ramsey (RHC.ASX) reported FY16 revenue of $8.6b up 18% on previous corresponding period, EBITDA of $1.2b, (up 15%) and core NPAT of $470m, (up $17+%).

FY16 dividends per share of $1.19, places the stock on a 1.5% yield.

You're not a member!  Trial today!

On a forward basis into FY17, we’re looking for EPS growth of 10%+ and a 5% uptick in revenue. Growth will moderate but still remains attractive, PE is high at 30x and a forecast yield of 1.8%, assuming $1.30 in DPS.

Last buy signal triggered at $68 in late June.

RHC

 

 

 

 

 

Author: Leon Hinde

Leon has been working in the financial services industry for 18 years in management and advisory roles. Leon has extensive experience in general advice and dealings involving securities and derivative financial products.

PS 146 Securities & Derivatives, ADA 1 & 2 accreditation, Responsible Manager Certificate. Leon is authorised to provide financial product advice and deal with respect to the following financial products:

· Deposit Products
· Securities
· Derivatives
· Interest in managed investment schemes; and
· Government debentures, bonds and stocks